Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
doi: 10.1159/000320559 9 BobbalaD.AlesutanI.FllerM.TschanS.HuberS
Warning: Do not exceed the recommended daily dose
Whilst manufacturers claim superior bioavailability compared to standard forms, independent clinical evidence supporting these claims in the context of liver disease remains limited
Metabolism 78 , 4351
First approved to treat MDS-related anemia in 2020 in patients who failed to respond to an erythropoiesis-stimulating (ESA) agentthe established front-line treatmentthe treatment will now be available to patients who have not received ESA therapy
US$ 27.86
US$ 26.50
US$ 24.11
US$ 24.31
US$ 29.21
